Prescriptions for antipsychotic medications to young children have doubled in the past 10 years.  With recent data showing that less than half had received a mental health assessment, there is growing concern among researchers and clinicians that many children may be misdiagnosed and overtreated.

TeenScreen Scientific Advisor Mark Olfson, MD, MPH, professor of clinical psychiatry at Columbia University and one of the nation’s foremost experts on the issue, highlights the latest research on the controversy, the risks of overmedication to young children and adolescents, and the confluence of factors that have produced these trends.

He proposes alternative strategies that could help ensure that the behavioral and mental health needs of children and adolescents continue to be met as effectively and safely as possible.

Click here to listen and view the webinar.